Weinberg's Pharma Omnium sells Biodim subsidiary
France-based Pharma Omnium International, a portfolio company of Weinberg Capital Partners (WCP), has sold its subsidiary Laboratoire Biodim to pharmaceutical business NuPharm, backed by Apax Partners.
More on Exits
Palamon announces roll-over investment into Ober Scharrer
GP sold Ober Scharrer to Nordic last year, generating a 3.6x return on its original investment
Syntaxis sells Polflam to Baltisse
Firm's founders Maciej Szamborski and Wojciech Wilczak also make an exit in the sale
Chequers, TCR sell Thermocoax to trade in €158m deal
TCR has been an investor in heating technology specialist Thermocoax since 2000
Innova Capital sells Neomedic in €70.5m deal
Sale of obstetrics-focused hospital group brings to an end a seven-year holding period
Latest News
Essling backs Evolucare Group
GP invests in the software company via Essling Expansion, a fund that recently held a first close
Naxicap-backed BVA bolts on Doxa
BVA expects to become one of the main market research groups in Europe and reach revenues of €200m
Palamon announces roll-over investment into Ober Scharrer
GP sold Ober Scharrer to Nordic last year, generating a 3.6x return on its original investment
Augmentum leads £150m debt and equity round for Iwoca
NIBC and existing investors including Prime also took part in the round for the SME lender